Cargando…
Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study
Importance: Diabetic macular edema (DME) is a major cause of vision loss in patients with diabetes mellitus. Intravitreal dexamethasone is a treatment option for patients unsuitable for or non-responsive to anti-angiogenic agents. Objective: To quantify visual and anatomical outcomes from an initial...
Autores principales: | Faes, Livia, Mishra, Amit V., Lipkova, Veronika, Balaskas, Konstantinos, Quek, Chrystie, Hamilton, Robin, Held, Ulrike, Sim, Dawn, Sivaprasad, Sobha, Fu, Dun Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299241/ https://www.ncbi.nlm.nih.gov/pubmed/37373573 http://dx.doi.org/10.3390/jcm12123878 |
Ejemplares similares
-
Visual acuity outcome of stable proliferative diabetic retinopathy following initial complete panretinal photocoagulation
por: Fu, Dun Jack, et al.
Publicado: (2022) -
Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema
por: Ramu, Jayashree, et al.
Publicado: (2017) -
Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema
por: Abdel-Hay, Ahmed, et al.
Publicado: (2018) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015) -
An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema
por: Sivaprasad, Sobha, et al.
Publicado: (2014)